The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Warfarin reversal
Open accessAbstract
Warfarin is the most commonly used oral anticoagulant in the UK. It is associated with few side effects apart from haemorrhage. The most appropriate way to reverse the anticoagulant effect of warfarin depends on the clinical circumstances. In serious bleeding, rapid reversal is required, whereas in minor bleeding or asymptomatic over anticoagulation, a more leisurely approach is usually appropriate. This review discusses the current approaches to warfarin reversal in clinical practice. The development of a uniform approach to warfarin reversal in the Northern Region is described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For VKAs, administration of fresh frozen plasma restores coagulation more rapidly than vitamin K, and prothrombin complex concentrates achieve even faster blood coagulation.505”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [505]
In the citing paper
“For VKAs, administration of fresh frozen plasma restores coagulation more rapidly than vitamin K, and prothrombin complex concentrates achieve even faster blood coagulation.505”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [505]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palareti, G., Leali, N., COCCHERI, S., Poggi, M., Manotti, C., D’Angelo, A., Pengo, V., Erba, N., Moia, M., CIAVARELLA, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,319
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,239
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 915
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
Landefeld, C. S., & Beyth, R. J. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90285-w · Cited by 897
Beyth, R. J., Quinn, L., & Landefeld, C. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00198-3 · Cited by 777
Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
Fihn, S. D., McDonell, M., Martin, D., Henikoff, J. G., Vermes, D., Kent, D., White, R. H., & for the Warfarin Optimized Outpatient Follow-up Study Group* (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00005 · Cited by 670
Managing Oral Anticoagulant Therapy
Ansell, J., Hirsh, J., Dalen, J. E., Bussey, H. I., Anderson, D., Poller, L., Jacobson, A. K., Deykin, D., & Matchar, D. B. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.22s · Cited by 576
Oral Anticoagulants and Intracranial Hemorrhage
Hart, R. G., Boop, B. S., & Anderson, D. C. (1995) · Stroke · doi:10.1161/01.str.26.8.1471 · Cited by 545
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
van der Meer, F. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.13.1557 · Cited by 539
Bleeding Complications in Oral Anticoagulant Therapy
van der Meer, F. J. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130073007 · Cited by 435
Research works printed but not linked: 2
- 2003, Br J Gen Pract, 53, 312
- 2002, Med Sci Monit, 8, 98
Cited by
Sorted by citations
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K. J., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 4,053
Costanzo, M. R., Costanzo, M. R., Dipchand, A. I., Starling, R. C., Anderson, A. S., Chan, M. C. Y., Desai, S., Fedson, S., Fisher, P. W., Gonzales-Stawinski, G. V., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.034 · Cited by 1,663
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Morgenstern, L. B., Hemphill, J. C., Anderson, C. S., Becker, K. J., Broderick, J. P., Connolly, E. S., Greenberg, S. M., Huang, J. N., Macdonald, R. L., Messe, S. R., et al. (2010) · Stroke · doi:10.1161/str.0b013e3181ec611b · Cited by 1,501
Metadata
- Authors
- Hanley, J. P.
- Affiliations
- Royal Victoria Infirmary (GB)
- Corresponding author
- Hanley, J P
- ORCID
- Hanley, J P
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2004-10-27
- Volume
- 57
- Issue
- 11
- Pages
- 1132-1139
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- PMC
- PMC1770479
- OpenAlex
- W4237953286
- Cited by
- 215
- References
- 76
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 4 · 2018: 7 · 2017: 12 · 2016: 14 · 2015: 14 · 2014: 6 · 2013: 16 · 2012: 11
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Pathology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Keywords
- warfarin reversal, oral anticoagulants, anticoagulant reversal, hemorrhage, overanticoagulation, northern regions
- MeSH terms
- Administration, Oral, Anticoagulants, Blood Coagulation, Blood Coagulation Factors, Child, Coagulants, Drug Administration Schedule, Factor VII, Hemorrhage, Humans, Plasma, Recombinant Proteins, Vitamin K, Warfarin, Factor VIIa, Practice Guidelines as Topic, Intracranial Hemorrhages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review